Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: CNS

NYU Langone Hospital Receives $250K from Cutting-Edge Alzheimer’s Disease Research

NYU’s Langone Hospital—Long Island just received a $250,000 grant from the Alzheimer’s Foundation of America (AFA) to expand and accelerate […]

NYU Langone Hospital Receives $250K from Cutting-Edge Alzheimer’s Disease Research
2 weeks ago
Share

Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor

Eli Lilly and Co inked a deal to gain worldwide, exclusive licensing rights to the autoimmune and inflammatory disease treatment […]

Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor
2 weeks ago
Share

Apple Watch Can Help Identify & Track Parkinson’s Disease Symptoms Based on New Study Results

With a growing array of smart applications, ubiquitous cloud compute infrastructure and Big Data, new forms of remote clinical research […]

Apple Watch Can Help Identify & Track Parkinson’s Disease Symptoms Based on New Study Results
1 month ago
Share

Jazz Pharmaceuticals Accesses First Approved Cannabidiol-based Medicine & Pipeline with $7.2b Acquisition of GW Pharmaceuticals Plc

Ireland-domiciled Jazz Pharmaceutical is apparently sold as the first developer of what is the first and only U.S. Food and […]

Jazz Pharmaceuticals Accesses First Approved Cannabidiol-based Medicine & Pipeline with $7.2b Acquisition of GW Pharmaceuticals Plc
1 month ago
Share

Dr. Ian Smith And Stuart Young Talk About Lessons From Covid-19: Strategy For Recruiting Patients

  An Interview with Dr. Ian Smith, Founder, Director and Chief Medical Officer of Panthera Biopartners and CEO of Panthera […]

1 month ago
Share

Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Secures $4.6m for Two Studies Investigating Lenalidomide in Early State Alzheimer’s Patients

The National Institute of Aging (NIA), part of the National Institutes of health (NIH) and the Alzheimer’s Drug Discovery Foundation […]

Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Secures $4.6m for Two Studies Investigating Lenalidomide in Early State Alzheimer’s Patients
1 month ago
Share

ADAPT-2 Study Results: Although Low, Overall Response Drug Combo May Help Some Meth Addicts

Although much attention has focused on the opioid epidemic, a parallel methamphetamine crisis rages on while the COVID-19 pandemic continues […]

ADAPT-2 Study Results: Although Low, Overall Response Drug Combo May Help Some Meth Addicts
2 months ago
Share

University of Buffalo Investigator Receives $3.1m from NIH to Investigate Impact of DBS on Parkinson’s Patients

Patients with Parkinson’s disease who are treated with deep brain stimulation (DBS) generally have unpredictable and varied speech outcomes after […]

University of Buffalo Investigator Receives $3.1m from NIH to Investigate Impact of DBS on Parkinson’s Patients
2 months ago
Share

Biogen & Apple Announce Virtual Study Involving Cognitive Decline Nationwide

Biogen recently announced a new digitally-powered virtual study in partnership with Apple to identify digital biomarkers to help monitor cognitive […]

Biogen & Apple Announce Virtual Study Involving Cognitive Decline Nationwide
2 months ago
Share

UC Riverside Serves As Lead Investigational Site for Study Evaluating Ecopipam for Adults Who Stutter

The School of Medicine at the University of California, Riverside (UC Riverside) will serve as lead investigational site for a […]

UC Riverside Serves As Lead Investigational Site for Study Evaluating Ecopipam for Adults Who Stutter
3 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.